CompanyDrug

NMPA Approves Two China-Developed COVID-19 Small-Molecule Therapies

Policy / Regulatory

China’s NHC Issues Guidelines to Improve Pediatric Medication Management

Policy / Regulatory

China’s Multi-Bureau Plan Aims to Eradicate Cervical Cancer by 2030

CompanyDrug

JS InnoPharm’s US Subsidiary Initiates Phase I Trial for AURKA Inhibitor VIC-1911

CompanyDeals

Akeso Receives First $300M Installment from Summit for Bispecific Antibody Ivonescimab

Policy / Regulatory

NMPA Proposes Emergency Use Management Measures for Medical Devices

CompanyDrug

InnoCare’s Gunagratinib Shows Promising Data in Cholangiocarcinoma at ASCO-GI 2023

CompanyDrug

Exegenesis Bio Gains FDA Approval for Gene Therapy EXG102-031 in Wet AMD

CompanyDrug

Simcere’s Cosela Receives First Prescription in China for CDK4/6 Inhibition

Policy / Regulatory

China Updates Export Controls on Technologies, Adds Gene Editing to List

CompanyDrug

Novartis’ Kisqali Receives NMPA Approval for Premenopausal Breast Cancer

CompanyDrug

Fosun Pharma’s Comirnaty Bivalent Vaccine Approved in Macau for Booster Shots